1123 related articles for article (PubMed ID: 30312399)
1. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
Sandesara PB; Virani SS; Fazio S; Shapiro MD
Endocr Rev; 2019 Apr; 40(2):537-557. PubMed ID: 30312399
[TBL] [Abstract][Full Text] [Related]
2. Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation.
Hoogeveen RC; Ballantyne CM
Clin Chem; 2021 Jan; 67(1):143-153. PubMed ID: 33257928
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
4. Remnant lipoproteins and atherosclerotic cardiovascular disease.
Tada H; Nohara A; Inazu A; Mabuchi H; Kawashiri MA
Clin Chim Acta; 2019 Mar; 490():1-5. PubMed ID: 30553862
[TBL] [Abstract][Full Text] [Related]
5. The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease.
Gabani M; Shapiro MD; Toth PP
Eur Cardiol; 2023; 18():e56. PubMed ID: 37860700
[TBL] [Abstract][Full Text] [Related]
6. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
Hussain A; Ballantyne CM; Saeed A; Virani SS
Curr Atheroscler Rep; 2020 Jun; 22(7):25. PubMed ID: 32494924
[TBL] [Abstract][Full Text] [Related]
7. Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
Wadström BN; Wulff AB; Pedersen KM; Nordestgaard BG
Curr Atheroscler Rep; 2023 Nov; 25(11):795-803. PubMed ID: 37768410
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease.
Heo JH; Jo SH
J Korean Med Sci; 2023 Sep; 38(38):e295. PubMed ID: 37750369
[TBL] [Abstract][Full Text] [Related]
9. Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention.
Quispe R; Sweeney T; Varma B; Agarwala A; Michos ED
Curr Atheroscler Rep; 2022 Oct; 24(10):767-778. PubMed ID: 35895246
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
Toth PP
Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia.
Moon JH; Kim K; Choi SH
Endocrinol Metab (Seoul); 2022 Aug; 37(4):575-586. PubMed ID: 36065644
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.
Ganda OP
Curr Opin Lipidol; 2023 Jun; 34(3):105-113. PubMed ID: 36924359
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.
Shaik A; Rosenson RS
Cardiovasc Drugs Ther; 2021 Jun; 35(3):677-690. PubMed ID: 33710501
[TBL] [Abstract][Full Text] [Related]
14. Genomics of hypertriglyceridemia.
Tada H; Takamura M; Kawashiri MA
Adv Clin Chem; 2020; 97():141-169. PubMed ID: 32448433
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.
Duran EK; Pradhan AD
Clin Chem; 2021 Jan; 67(1):183-196. PubMed ID: 33409533
[TBL] [Abstract][Full Text] [Related]
16. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management.
Ganda OP; Bhatt DL; Mason RP; Miller M; Boden WE
J Am Coll Cardiol; 2018 Jul; 72(3):330-343. PubMed ID: 29935936
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
Berman AN; Blankstein R
Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
[TBL] [Abstract][Full Text] [Related]
18. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
[TBL] [Abstract][Full Text] [Related]
19. Targeting triglycerides to lower residual cardiovascular risk.
Bubb KJ; Nelson AJ; Nicholls SJ
Expert Rev Cardiovasc Ther; 2022 Mar; 20(3):185-191. PubMed ID: 35323080
[TBL] [Abstract][Full Text] [Related]
20. Genetics of hypertriglyceridemia and atherosclerosis.
Gill PK; Dron JS; Hegele RA
Curr Opin Cardiol; 2021 May; 36(3):264-271. PubMed ID: 33818545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
